Annual Reports

 
Quarterly Reports

  • 10-Q (Nov 6, 2009)
  • 10-Q (Aug 13, 2009)
  • 10-Q (May 14, 2009)
  • 10-Q (Nov 6, 2008)
  • 10-Q (Aug 7, 2008)
  • 10-Q (May 8, 2008)

 
8-K

 
Other

Aspect Medical Systems 10-Q 2007

Documents found in this filing:

  1. 10-Q/A
  2. Ex-31.1
  3. Ex-31.2
  4. Ex-32.1
  5. Ex-32.2
  6. Ex-32.2
e10vqza
 

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-Q/A
(Amendment No. 1)
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2007
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to           
Commission file number: 0-24663
 
Aspect Medical Systems, Inc.
(Exact name of Registrant as Specified in Its Charter)
     
Delaware   04-2985553
(State or Other Jurisdiction of   (I.R.S. Employer
Incorporation or Organization)   Identification No.)
     
One Upland Road   02062-1546
Norwood, Massachusetts   (Zip Code)
(Address of Principal Executive Offices)    
(617) 559-7000
Registrant’s telephone number, including area code
 
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered Pursuant to Section 12(g) of the Act:
Common Stock, $0.01 Par Value
(Title Of Class)
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES x     NO o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.
Large accelerated filer o     Accelerated filer x     Non-accelerated filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES o     NO x
The Registrant had 16,994,654 shares of Common Stock, $0.01 par value per share, outstanding as of August 1, 2007.
 
 

 


 

Explanatory Note
This Amendment No. 1 to Quarterly Report on Form 10-Q/A (“Amendment No. 1”) is being filed to correct the number of shares of the registrant’s common stock outstanding as of August 1, 2007 included on the cover page of the registrant’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2007, filed with the Securities and Exchange Commission on August 9, 2007 (“Original Form 10-Q”).
Pursuant to Rule 12b-15 promulgated under the Securities Exchange Act of 1934, the registrant is filing updated exhibits 31.1, 31.2, 32.1 and 32.2. in connection with filing Amendment No. 1.
Except for the matters described above, Amendment No. 1 does not modify or update disclosure in, or exhibits to, the Original Form 10-Q. Furthermore, except for the matters described above, Amendment No. 1 does not change any previously reported financial results, nor does it reflect events occurring after the date of the Original Form 10-Q. Any information not affected by Amendment No. 1 is unchanged and reflects the disclosures made at the time the Original Form 10-Q was filed.

 


 

SIGNATURES
     Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
    ASPECT MEDICAL SYSTEMS, INC.
 
       
Date: August 17, 2007
       
 
       
 
  By:   /s/ Michael Falvey
 
       
 
      Michael Falvey
Vice President and Chief Financial Officer

 


 

EXHIBIT INDEX
     
EXHIBIT    
NUMBER   EXHIBIT
31.1
  Certification by Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended.
 
   
31.2
  Certification by Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended.
 
   
32.1
  Certification by Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
   
32.2
  Certification by Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki